§ 12–6A-06
Statutes in effect as of October 1, 2026.
Md. Code Ann., Health Occ. § 12-6A-06 (2026)
Title 12. Pharmacists and Pharmacies
Subtitle 6A. Therapy Management Contracts
§ 12–6A-06LinkCopy Citation
(a)
A protocol under this subtitle:
(1)
May authorize:
(i)
For protocols by a licensed physician and licensed pharmacist, the initiation of drug therapy under written, disease–state specific protocols;
(ii)
The modification, continuation, and discontinuation of drug therapy under written, disease–state specific protocols;
(iii)
The ordering of laboratory tests; and
(iv)
Other patient care management measures related to monitoring or improving the outcomes of drug or device therapy; and
(2)
May not authorize acts that exceed the scope of practice of the parties to the therapy management contract.
(b)
A protocol shall prohibit the substitution of a chemically dissimilar drug product by the pharmacist for the product prescribed by the authorized prescriber, unless permitted in the therapy management contract.
(c)
A protocol that authorizes controlled dangerous substances drug therapy shall require the pharmacist to request relevant data from the Prescription Drug Monitoring Program before initiating or modifying a controlled dangerous substances drug therapy.